Mental health concerns in children with neurodevelopmental conditions attending a developmental assessment service
Journal of Affective Disorders · 2023
DOI: 10.1016/j.jad.2023.04.098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2023. Verfasst von Kelsie A Boulton und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinic for Autism and Neurodevelopment (CAN) research, Brain and Mind Centre, Children's Hospital Westmead Clinical School, Faculty of Medicine and H…. Hauptthemen laut MEDLINE: Neurodevelopmental Disorders, Attention Deficit Disorder with Hyperactivity. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Children with neurodevelopmental conditions (NDCs), such as autism and attention-deficit/hyperactivity disorder (ADHD), frequently experience co-occurring mental health concerns. Little research has examined mental health symptoms in children attending developmental assessment services. This study profiled mental health symptoms in children with NDCs attending a hospital-based diagnostic service for their first diagnostic and developmental assessment. Participants were 232 children aged 1.96-17.51 years. Mental health concerns were assessed using the Child Behavior Checklist (CBCL), a caregiver-rated, questionnaire-based assessment of behavioural and emotional difficulties. Subclinical or clinically elevated internalising, externalising and total scores on the CBCL were reported in approximately 48% of preschool and 61% of school-age children. These increased prevalence rates, using the same cutoff scores, remained after excluding items specifically relating to neurodevelopmental concerns (36% preschool; 37% school-age children). More school-aged females reported elevated internalising problems, relative to males (67 % vs 48 %). The number of diagnoses impacted symptoms, with children who received two or more DSM-5 diagnoses showing a greater rate of subclinical or clinically elevated scores, relative to children who received one DSM-5 diagnosis. Our findings demonstrate that children attending developmental assessment services have considerable mental health needs. It is critical that mental health concerns are identified and addressed in children when they first present to developmental assessment services, and that service providers are equipped to provide appropriate resources and pathways to ongoing care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinic for Autism and Neurodevelopment (CAN) research, Brain and Mind Centre, Children's Hospital Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Australia; Child Neurodevelopment and Men…
- Child Development Unit, The Children's Hospital at Westmead, Westmead, NSW 2145, Australia; Child Neurodevelopment and Mental Health Team, Brain and Mind Centre, University of Sydney, Australia.
- Child Development Unit, The Children's Hospital at Westmead, Westmead, NSW 2145, Australia.
Zitieren
APA
Boulton, K. A., Guastella, A. J., Hodge, M. A., Demetriou, E. A., Ong, N., & Silove, N. (2023). Mental health concerns in children with neurodevelopmental conditions attending a developmental assessment service. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2023.04.098
Vancouver
Boulton KA, Guastella AJ, Hodge MA, Demetriou EA, Ong N, Silove N. Mental health concerns in children with neurodevelopmental conditions attending a developmental assessment service. Journal of Affective Disorders. 2023. doi:10.1016/j.jad.2023.04.098
BibTeX
@article{Boulton2023,
author = {Boulton, Kelsie A and Guastella, Adam J and Hodge, Marie-Antoinette and Demetriou, Eleni A and Ong, Natalie and Silove, Natalie},
title = {Mental health concerns in children with neurodevelopmental conditions attending a developmental assessment service},
journal = {Journal of Affective Disorders},
year = {2023},
doi = {10.1016/j.jad.2023.04.098}
}
EUVIMED